Perspectives of HIV specialists and cardiologists on the specialty referral process for people living with HIV: a qualitative descriptive study.
Perspectives of HIV specialists and cardiologists on the specialty referral process for people living with HIV: a qualitative descriptive study.
复制标题
DOI：
10.1186/s12913-022-08015-0
复制
发表时间：
2022-05-09
影响因子：
2.8
通讯作者：
Bloomfield, Gerald S.
中科院分区：
文献类型：
--
作者：
Muiruri, Charles;Corneli, Amy;Cooper, Linda;Dombeck, Carrie;Gray, Shamea;Longenecker, Chris T.;Meissner, Eric G.;Okeke, Nwora Lance;Pettit, April C.;Swezey, Teresa;Vicini, Joseph;Bloomfield, Gerald S.
心脏病护理可能有利于艾滋病毒感染者（PLWH）的风险因素管理，但从艾滋病毒专家和心脏病专家的角度来看，有关转诊过程的信息有限。从2019年12月到2020年2月，我们在美国的学术医疗中心进行了28次定性访谈，使用了专科转诊流程框架的组成部分：转诊决定，进入转诊护理和护理整合。我们使用应用主题分析法对数据进行了分析。心脏科转诊的原因最常见的包括二级预防，不受控制的风险因素，心脏症状和药物管理。转诊过程中的促进因素包括转诊的便利性、艾滋病毒专家和心脏病专家之间的个人关系以及诊所离患者家很近。障碍包括缺乏交通工具，交通费用，保险覆盖范围的差距，耻辱和病人不情愿。我们的研究结果将为未来的研究提供信息，旨在改善PLWH的专业转介过程的实施策略。ClinicalTrials.gov标识符：NCT 04025125。在线版本包含补充材料，可通过10.1186/s12913-022-08015-0获得。
Cardiology care may be beneficial for risk factor management in people living with HIV (PLWH), yet limited information is available about the referral process from the perspectives of HIV specialists and cardiologists. We conducted 28 qualitative interviews at academic medical centers in the United States from December 2019 to February 2020 using components of the Specialty Referral Process Framework: referral decision, entry into referral care, and care integration. We analyzed the data using applied thematic analysis. Reasons for cardiology referral most commonly included secondary prevention, uncontrolled risk factors, cardiac symptoms, and medication management. Facilitators in the referral process included ease of referral, personal relationships between HIV specialists and cardiologists, and close proximity of the clinic to the patient’s home. Barriers included lack of transportation, transportation costs, insurance coverage gaps, stigma, and patient reluctance. Our results will inform future studies on implementation strategies aimed at improving the specialty referral process for PLWH. ClinicalTrials.gov Identifier: NCT04025125. The online version contains supplementary material available at 10.1186/s12913-022-08015-0.
登录
查看更多内容
影响因子：
4.7
作者：
Kiger, Michelle E.;Varpio, Lara
通讯作者：
Varpio, Lara
影响因子：
5.4
作者：
Ladapo, Joseph A.;Richards, Adam K.;Mafi, John N.
通讯作者：
Mafi, John N.
DOI：
10.1016/j.jana.2013.07.006
发表时间：
2014-01
影响因子：
2
作者：
Cioe, Patricia A.;Crawford, Sybil L.;Stein, Michael D.
通讯作者：
Stein, Michael D.
影响因子：
39
作者：
Freiberg MS;Chang CC;Kuller LH;Skanderson M;Lowy E;Kraemer KL;Butt AA;Bidwell Goetz M;Leaf D;Oursler KA;Rimland D;Rodriguez Barradas M;Brown S;Gibert C;McGinnis K;Crothers K;Sico J;Crane H;Warner A;Gottlieb S;Gottdiener J;Tracy RP;Budoff M;Watson C;Armah KA;Doebler D;Bryant K;Justice AC
通讯作者：
Justice AC
影响因子：
2.2
作者：
Muiruri, Charles;Sico, Isabelle P.;Bosworth, Hayden B.
通讯作者：
Bosworth, Hayden B.